Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Equipment >

BioSig Technologies, Inc. (BSGM)

Add BSGM Price Alert      Hide Sticky   Hide Intro
Moderator: mick
Search This Board: 
Last Post: 8/21/2017 11:14:07 AM - Followers: 15 - Board type: Free - Posts Today: 0

01-18-2017 / 13 pg. referennce/

BioSig Technologies, Inc. (BSGM) is a medical device company that has developed a proprietary technology platform

designed to greatly improve the rapidly growing $3 billion electrophysiology (EP) marketplace.

Led by a proven management team and a veteran, independent Board of Directors, Los Angeles-based BioSig is preparing to commercialize its PURE EP System.

PURE EP is designed to improve outcomes of EP studies and cardiac catheter ablation, shorten procedure times and reduce recurrence rates.

It is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings and provide guidance in identifying ablation targets -

areas of tissue to destroy that otherwise create a heart rhythm disturbance (arrhythmia).

BioSig believes this information is not easily obtained, if at all, from any other EP equipment in the market today.

These ablation procedures treat cardiac arrhythmias, which are broadly defined as a set of conditions in which the electrical

activity of the heart is irregular, or faster or slower than normal.

This type of heart disease afflicts 14.4 million Americans, or one in 18.

Two of the most prevalent and deadly types of arrhythmias today are Atrial Fibrillation (AF) and Ventricular Tachycardia (VT).

According to the American Heart Association, AF increases an individual's risk of stroke (fourth leading cause of death in the US) four to five-fold.

AF is the most common arrhythmia with 2.7 million cases in 2010 in the US, forecast to grow to 5.6 million cases by 2050.

In the US alone, AF leads to about 600,000 hospitalizations/year with a direct cost of about $6 billion annually and, adding indirect costs, brings the AF total cost to $26 billion.

Analysts forecast the global market for EP devices will grow at a 12.1 percent compound annual growth rate from $2.5 billion in 2012 to $5.5 billion by 2019 making it one of the fastest growing cardiovascular medical technology segments.

Just in the US, the number of AF and VT ablations is forecast to grow at 10.5 percent from 2012 to 2017. BioSig will seek FDA 510(k) approval for its PURE EP System.

The Company has achieved proof of concept validation through UCLA EP & Animal Labs ongoing from May 2013. BioSig is collaborating with
several of the nation's most prestigious cardiac arrhythmia centers to develop, refine and, ultimately, commercialize the PURE EP System,
Including: Texas Cardiac Arrhythmia Institute UCLA Cardiac Arrhythmia Center U.H. Case Medical Center in Cleveland
William Beaumont Hospital in Michigan Mount Sinai Medical Center in NY Mayo Clinic in Minnesota


Share Structure

Shares outstanding: 17 million
Recent price: $1.29
Market cap: $ 21.9 million
Insider ownership: 50%
Float: 6 million

With a novel product nearing commercialization which addresses a need in the global cardiology market, BioSig Technologies became public by filing an S-1 registration statement for an IPO, and began trading in November of 2014. Insiders have been buying shares regularly, (see recent transactions), and the process of uplisting to NASDAQ has begun. Uplisting to NASDAQ is projected to be completed in “early 2016.


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BSGM News: Post-effective Amendment to Registration Statement (pos Am) 08/03/2017 05:32:50 PM
BSGM News: Post-effective Amendment to Registration Statement (pos Am) 08/03/2017 05:25:21 PM
BSGM News: Post-effective Amendment to Registration Statement (pos Am) 08/03/2017 05:18:30 PM
BSGM News: Securities Registration Statement (s-1/a) 08/03/2017 05:07:36 PM
BSGM News: Current Report Filing (8-k) 08/03/2017 04:54:06 PM
#31  Sticky Note $BSGM recent news/filings mick 04/17/15 04:15:25 PM
#254   The stock is traded in between $1.20 and IPO$ 08/21/17 11:14:07 AM
#253   Biosig Technologies, (BSGM) mick 07/09/17 11:46:04 AM
#252   75 cents for recent Form 4 stock sales? pevesturner 06/27/17 09:25:59 PM
#251   75 cents for recent Form 4 stock sales? pevesturner 06/27/17 09:25:47 PM
#250   They both still own over 3 million shares. richierich1220 06/09/17 12:40:01 PM
#249   200,000 shares sold by Executive Chairman and Largest 236T568 06/09/17 11:46:41 AM
#248   200,000 shares sold by BSGM's 2nd Largest Stockholder 236T568 06/07/17 07:54:43 PM
#247   BSGM CEO TERMINATED ABRUTLY - Gregory Cash, President, 236T568 06/05/17 06:20:17 PM
#246   BSGM Executive Chairman and Director Kenneth L. Londoner 236T568 06/05/17 06:18:11 PM
#245   I see $1.36 north40000 06/05/17 03:36:13 PM
#244   Oh my! $1.23 and dropping! 236T568 06/05/17 11:14:38 AM
#243   BSGM CEO TERMINATED ABRUTLY - Gregory Cash, President, 236T568 06/02/17 05:34:33 PM
#242   What does all that mean in that registration richierich1220 05/25/17 05:15:45 PM
#241   BSGM News: Post-effective Amendment to Registration Statement (pos mick 05/24/17 07:33:45 AM
#240   Biosig Technologies, (BSGM) mick 05/24/17 07:33:39 AM
#239   BSGM Executive Chairman and Director Kenneth L. Londoner 236T568 05/22/17 02:29:06 PM
#238   BSGM Executive Chairman and Director Kenneth L. Londoner 236T568 05/15/17 01:51:07 PM
#237   Biosig Technologies, (BSGM) mick 04/27/17 02:49:06 PM
#236   Biosig Technologies, (BSGM) mick 04/08/17 01:20:04 PM
#235   BSGM ZERO Revenues for 2016 236T568 03/31/17 03:47:56 PM
#234   BSGM Net Loss $11.7 million for 2016 236T568 03/31/17 03:47:15 PM
#233   Mr. Londoner failed to file 93 Form 4 236T568 03/31/17 05:12:41 AM
#232   Section 16(a) Beneficial Ownership Reporting Compliance 236T568 03/31/17 05:11:21 AM
#231   Ouch! BSGM drops to $1.20 today 236T568 03/30/17 11:29:06 AM
#230   Don't fool yourself will be back near 1.50 vhgier 03/30/17 11:25:40 AM
#229   BSGM - defines what a fluff press release 236T568 03/30/17 10:44:04 AM
#228   News. Sell. Five Lafayette College students willlbone 03/30/17 10:24:51 AM
#227   I don't know I was simply asking if Dogman 1955 03/23/17 12:00:23 PM
#226   BSGM and Mayo - BSGM behaving like a 236T568 03/22/17 09:30:49 PM
#225   BSGM News: Current Report Filing (8-k) 03/21/2017 04:42:55 PM mick 03/22/17 06:11:03 PM
#224   Biosig Technologies, (BSGM) mick 03/22/17 06:10:56 PM
#223   YOu guys are so wrong look at product silkman 03/22/17 06:01:38 PM
#222   They are using Beat Penny Stocks Dot COM Dogman 1955 03/22/17 04:51:32 PM
#221   The massive paid stock promotion of BSGM continues 236T568 03/22/17 12:36:06 PM
#220   BSGM and Mayo - BSGM behaving like a 236T568 03/21/17 07:42:39 PM
#219   I didn't realize that. Was wondering why richierich1220 03/21/17 03:24:47 PM
#218   Okidoki thx bro.. ! vhgier 03/21/17 01:12:46 PM
#217   yep and Do 236T568 03/21/17 01:12:16 PM
#216   Do you have a link or is it promoters? vhgier 03/21/17 01:04:45 PM
#215   You do understand that there is another paid 236T568 03/21/17 01:00:08 PM
#214   Richie it is finally. We cross 1.60 vhgier 03/21/17 12:51:17 PM
#213   I hope this stock starts to do something richierich1220 03/13/17 10:19:05 AM
#212   BSGM News: Current Report Filing (8-k) 02/14/2017 02:00:19 PM mick 02/22/17 12:10:49 PM
#211   Biosig Technologies, (BSGM) mick 02/22/17 12:10:35 PM
#210   Biosig Technologies, (BSGM) mick 01/21/17 10:54:33 PM
#209   Short volume has nothing to do with actual rbtree 01/20/17 12:17:41 PM
#208   See-through equity issued a nice report on the IPO$ 01/19/17 02:59:46 PM
#207   Historical Short Volume Data for BSGM mick 01/19/17 09:24:18 AM
#206 mick 01/19/17 09:22:35 AM
#205   Recent News/ mick 01/19/17 09:20:10 AM